Safer DNA and RNA delivery tested in mice and monkeys
Live Forever Club - 17-Sep-2025This could help treat many diseases by fixing problems at the source
Join the club for FREE to access the whole archive and other member benefits.
Comapny developing next generation nucleic acid-based therapies using proprietary Fusogenix drug delivery system.
Entos Pharmaceuticals is focused on the development of next generation nucleic acid-based therapies using their proprietary Fusogenix drug delivery system. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. The technology is applicable to a wide range of therapeutic types including gene therapy, mRNA, miRNA, RNAi and CRISPR.
Visit website: https://www.entospharma.com/
Details last updated 03-Feb-2020
This could help treat many diseases by fixing problems at the source